Table 6.

Multidisciplinary Teams and Referral

	PCP (n = 318)	Hepatology (n = 57)	Gastroenterology (n = 156)	Endocrinology (n = 98)
Would you involve any other clinicians or medical specialists in the initial management of a patient diagnosed with NASH? (select all that apply)
Yes, dietitian or nutritionist	59%	72%	54%	50%
Yes, endocrinologist	21%	47%	33%	–
Yes, gastroenterologist/ hepatologist	64%	–	–	67%
Yes, obesity specialist or bariatrician	21%	39%	21%	17%
Yes, primary care physician	8%	51%	30%	19%
Yes, other	2%	2%	2%	1%
No	15%	16%	33%	24%
Unsure	8%	7%	8%	5%
Which of the following patients would you refer to a gastroenterologist or hepatologist for further workup or management of NAFLD/NASH? A patient with … ?* (select all that apply)
Any risk factors for NAFLD/NASH	19%			14%
Elevated liver enzymes in the context of risk factors for NAFLD/NASH	53%			55%
Any evidence of fatty liver by imaging	22%	–	–	25%
Fatty liver on imaging after other causes have been excluded	40%			40%
NAFLD at high risk for advanced fibrosis or cirrhosis	91%			88%
Other	2%			1%
None of these	1%			1%
What is your role in the ongoing management of a patient’s NAFLD/NASH after referral to a specialist?* (select all that apply)
Ordering diagnostic testing based on the specialist’s recommendations	61%			43%
Discussing treatment options with the patient	52%			51%
Oordinating care between multiple specialists	80%	–	–	47%
Reinforcing or modifying lifestyle management recommendations	88%			82%
Monitoring for treatment side effects and disease complications	71%			56%
Educating on tests or treatments for NASH	60%			51%
Monitoring for and managing drug side effects	63%			60%
Other	0%			4%
No ongoing role	1%			2%

Note: *Only on primary care and endocrinology clinician surveys.